| abstract |
The present invention relates to conjugates of therapeutic agents or active agents with melanotransferrin or other ligands of melanotransferrin receptors, melanotransferrin modulators and related compositions, and such conjugates, ligands and modulators in vitro or in vivo. Methods of modulating blood brain barrier transport by providing methods of screening and selection in, and such conjugates, modulators and ligands in the diagnosis and treatment of diseases, particularly including central nervous system diseases or lysosomal storage diseases Provide usage of. |